Evaluation effect of Pramipexole in patients with migraine and restless legs syndrome at the same time

Phase 3

• Conditions: Migrain, restless legs syndrome.; Migraine, Other extrapyramidal and movement disorders; G43, G26

• Registration Number: IRCT2016022026166N1
• Lead Sponsor: Vice chancellor for research of Ahwaz Jundishapour university of medical science

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Main inclusion criteria: No pregnant weman? No menopause weman ?No history of Alcohol or substance addiction ?No history of cardiac block or bradycardia?No history of second cause for restless legs syndrome
Main exclusion criteria: Patient who stop continuing the study in each reason; Patient who will be menopause or pregnant

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Severity of Miigrain. Timepoint: Start and after 3 months. Method of measurement: Midas questionary.;Severity of restless leg syndrome. Timepoint: Start and after 3 months. Method of measurement: IRLLG questionary.